MOH — authorised 20 December 2019
- Marketing authorisation holder: DAIICHI SANKYO
- Status: likely_approved
🇮🇱 Enhertu in Israel
MOH authorised Enhertu on 20 December 2019
Marketing authorisation
Enhertu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Enhertu approved in Israel?
Yes. MOH authorised it on 20 December 2019.
Who is the marketing authorisation holder for Enhertu in Israel?
DAIICHI SANKYO holds the Israeli marketing authorisation.